Review




Structured Review

Procell Inc h460 cells
A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. <t>H460</t> cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
H460 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pmc13194821-296-10-12?v=Procell+Inc
Average 86 stars, based on 1 article reviews
h460 cells - by Bioz Stars, 2026-06
86/100 stars

Images

1) Product Images from "Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity"

Article Title: Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity

Journal: Nature Communications

doi: 10.1038/s41467-026-70764-x

A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. H460 cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Figure Legend Snippet: A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. H460 cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Techniques Used: CRISPR, Expressing, Western Blot, Control, Plasmid Preparation, Cell Culture, Co-Culture Assay, Derivative Assay

A Top five identified positive regulators ranked by enrichment scores from the immunoprecipitation-mass spectrometry (IP-MS) screen. Immunoprecipitation was performed using anti-FLAG beads in HEK293T cells transfected using TM9SF2 -FLAG. For B – E , G , HA antibody is used for the detection of HA-tagged PGK1. B Co-immunoprecipitation assays validating the interactions between TM9SF2 and PGK1 in H460 cells after 48 h of IFN-γ stimulation (100 ng/mL). C Western blot analysis of PGK1 and PD-L1 in H460 cells transduced with PGK1 sgRNAs versus sgNTC or H460 cells overexpressing HA-tagged PGK1 ( n = 3 independent experiments). D Co-immunoprecipitation assays demonstrating the association between TM9SF2 and PGK1 wild-type, S203D (phosphorylation-mimetic mutant), or S203A (phosphorylation-deficient mutant). E Western blot analysis of PD-L1 levels in PGK1 -depleted H460 cells transfected with PGK1 wild type or phospho-mutants. F , G The half-life of PD-L1 was assessed in H460 cells with PGK1 depletion or overexpression following treatment with CHX (25 µg/mL). For H – J , C57BL/6 J mice underwent subcutaneous injection with B16 cells transduced with Pgk1 shRNA or control shRNA. H Representative images and volumes of B16 tumors. I Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). J Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). K Schematic of the experimental design: For L-N, C57BL/6 J mice were subcutaneously inoculated with B16 cells followed by daily intraperitoneal administration of DC-PGKI (a PGK1 inhibitor, 5 and 10 mg/kg) for one week. L Representative image of B16 tumors. M Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). N The proportions of IFN-γ + and CD107a + tumor-permeating CD8 + T cells in tumors ( n = 5 mice). For O – Q , C57BL/6 J mice were injected with B16 cells overexpressing Pgk1 or EV. O Representative image of B16 tumors. P Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Q Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Figure Legend Snippet: A Top five identified positive regulators ranked by enrichment scores from the immunoprecipitation-mass spectrometry (IP-MS) screen. Immunoprecipitation was performed using anti-FLAG beads in HEK293T cells transfected using TM9SF2 -FLAG. For B – E , G , HA antibody is used for the detection of HA-tagged PGK1. B Co-immunoprecipitation assays validating the interactions between TM9SF2 and PGK1 in H460 cells after 48 h of IFN-γ stimulation (100 ng/mL). C Western blot analysis of PGK1 and PD-L1 in H460 cells transduced with PGK1 sgRNAs versus sgNTC or H460 cells overexpressing HA-tagged PGK1 ( n = 3 independent experiments). D Co-immunoprecipitation assays demonstrating the association between TM9SF2 and PGK1 wild-type, S203D (phosphorylation-mimetic mutant), or S203A (phosphorylation-deficient mutant). E Western blot analysis of PD-L1 levels in PGK1 -depleted H460 cells transfected with PGK1 wild type or phospho-mutants. F , G The half-life of PD-L1 was assessed in H460 cells with PGK1 depletion or overexpression following treatment with CHX (25 µg/mL). For H – J , C57BL/6 J mice underwent subcutaneous injection with B16 cells transduced with Pgk1 shRNA or control shRNA. H Representative images and volumes of B16 tumors. I Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). J Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). K Schematic of the experimental design: For L-N, C57BL/6 J mice were subcutaneously inoculated with B16 cells followed by daily intraperitoneal administration of DC-PGKI (a PGK1 inhibitor, 5 and 10 mg/kg) for one week. L Representative image of B16 tumors. M Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). N The proportions of IFN-γ + and CD107a + tumor-permeating CD8 + T cells in tumors ( n = 5 mice). For O – Q , C57BL/6 J mice were injected with B16 cells overexpressing Pgk1 or EV. O Representative image of B16 tumors. P Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Q Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Techniques Used: Immunoprecipitation, Mass Spectrometry, Protein-Protein interactions, Transfection, Western Blot, Transduction, Phospho-proteomics, Mutagenesis, Over Expression, Injection, shRNA, Control, Flow Cytometry

A Bar plot showing altered cellular processes and signaling pathways in shTM9SF2 H460 cells compared to shNC cells. B A schematic of the PD-L1 surface internalization assay in H460 cells transduced with sgRNAs is shown. C Surface PD-L1 retention in H460 cells was measured by flow cytometry after genetic depletion of PGK1 or TM9SF2 ( n = 3 independent experiments). D PD-L1 recycling was quantified by flow cytometry in H460 cells following PGK1 or TM9SF2 knockout ( n = 3 independent experiments). E Immunofluorescence showing PD-L1 colocalization with RAB11 in sg PGK1 or sg TM9SF2 H460 cells versus sgNTC (PD-L1 in green, RAB11 in red, DAPI in blue). Scale bar: 5 μm. The right panels display intensity profiles of PD-L1 versus RAB11 following the white line. For F , G , HA antibody is used for the detection of HA-tagged PGK1. F Co-immunoprecipitation assay demonstrating TM9SF2 interaction with PGK1, RAB11, and PD-L1 in H460 cells, with or without IFN-γ treatment (100 ng/mL, 48 h). G Co-immunoprecipitation assay evaluating interactions of PGK1 wild-type and its phospho-mutants (S203A and S203D) using TM9SF2, PD-L1, and RAB11 in H460 cells. Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Figure Legend Snippet: A Bar plot showing altered cellular processes and signaling pathways in shTM9SF2 H460 cells compared to shNC cells. B A schematic of the PD-L1 surface internalization assay in H460 cells transduced with sgRNAs is shown. C Surface PD-L1 retention in H460 cells was measured by flow cytometry after genetic depletion of PGK1 or TM9SF2 ( n = 3 independent experiments). D PD-L1 recycling was quantified by flow cytometry in H460 cells following PGK1 or TM9SF2 knockout ( n = 3 independent experiments). E Immunofluorescence showing PD-L1 colocalization with RAB11 in sg PGK1 or sg TM9SF2 H460 cells versus sgNTC (PD-L1 in green, RAB11 in red, DAPI in blue). Scale bar: 5 μm. The right panels display intensity profiles of PD-L1 versus RAB11 following the white line. For F , G , HA antibody is used for the detection of HA-tagged PGK1. F Co-immunoprecipitation assay demonstrating TM9SF2 interaction with PGK1, RAB11, and PD-L1 in H460 cells, with or without IFN-γ treatment (100 ng/mL, 48 h). G Co-immunoprecipitation assay evaluating interactions of PGK1 wild-type and its phospho-mutants (S203A and S203D) using TM9SF2, PD-L1, and RAB11 in H460 cells. Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Techniques Used: Protein-Protein interactions, Transduction, Flow Cytometry, Knock-Out, Immunofluorescence, Co-Immunoprecipitation Assay

A Heatmap showing increased proteins involved in PD-L1 lysosomal degradation in sgPGK1 H460 cells versus sgNTC cells. Western blot of HIP1R levels in sg PGK1 ( B ) and sg TM9SF2 ( C ) H460 cells versus sgNTC cells ( n = 3 independent experiments). For D – F , HA antibody is used for the detection of HA-tagged PGK1. D Half-life analysis of HIP1R abundance in CHX (25 μg/mL)-treated H460 cells with PGK1 depletion or HA- PGK1 overexpression. E Western blot analyses of HIP1R ubiquitination in H460 cells reconstituted with MYC- HIP1R and HA- PGK1 for 36 h, followed by treatment with MG132 (10 μM, 8 h) and with or without IFN-γ administration (100 ng/mL, 8 h). MYC antibody is used for the detection of MYC-tagged HIP1R. F Western blot analyses of HIP1R ubiquitination in HEK293T cells reconstituted using MYC- HIP1R and HA- PGK1 wild-type and phospho-mutants for 36 h, followed by MG132 treatment (10 μM, 8 h). G Co-immunoprecipitation analysis examining IFN-γ effects on PGK1 association with GFP-HIP1R Δ966-979 and GFP-HIP1R. H460 cells transfected with FLAG- PGK1 and either GFP- HIP1R or GFP- HIP1R Δ966-979 were treated with IFN-γ (100 ng/mL, 8 h). Flag antibody is used for the detection of FLAG-tagged PGK1 and GFP antibody is used for the detection of GFP-tagged HIP1R. H A schematic of GFP fusion constructs is shown, including HIP1R lysosomal sorting signal (LL/LI, GFP-S1) and its corresponding mutant (AA, GFP-S2). I CHX-chase assay showing GFP-S1 and GFP-S2 protein levels over time in sg PGK1 or sgNTC H460 cells treated with CHX (25 μg/mL). Source data are provided as a file.
Figure Legend Snippet: A Heatmap showing increased proteins involved in PD-L1 lysosomal degradation in sgPGK1 H460 cells versus sgNTC cells. Western blot of HIP1R levels in sg PGK1 ( B ) and sg TM9SF2 ( C ) H460 cells versus sgNTC cells ( n = 3 independent experiments). For D – F , HA antibody is used for the detection of HA-tagged PGK1. D Half-life analysis of HIP1R abundance in CHX (25 μg/mL)-treated H460 cells with PGK1 depletion or HA- PGK1 overexpression. E Western blot analyses of HIP1R ubiquitination in H460 cells reconstituted with MYC- HIP1R and HA- PGK1 for 36 h, followed by treatment with MG132 (10 μM, 8 h) and with or without IFN-γ administration (100 ng/mL, 8 h). MYC antibody is used for the detection of MYC-tagged HIP1R. F Western blot analyses of HIP1R ubiquitination in HEK293T cells reconstituted using MYC- HIP1R and HA- PGK1 wild-type and phospho-mutants for 36 h, followed by MG132 treatment (10 μM, 8 h). G Co-immunoprecipitation analysis examining IFN-γ effects on PGK1 association with GFP-HIP1R Δ966-979 and GFP-HIP1R. H460 cells transfected with FLAG- PGK1 and either GFP- HIP1R or GFP- HIP1R Δ966-979 were treated with IFN-γ (100 ng/mL, 8 h). Flag antibody is used for the detection of FLAG-tagged PGK1 and GFP antibody is used for the detection of GFP-tagged HIP1R. H A schematic of GFP fusion constructs is shown, including HIP1R lysosomal sorting signal (LL/LI, GFP-S1) and its corresponding mutant (AA, GFP-S2). I CHX-chase assay showing GFP-S1 and GFP-S2 protein levels over time in sg PGK1 or sgNTC H460 cells treated with CHX (25 μg/mL). Source data are provided as a file.

Techniques Used: Western Blot, Over Expression, Ubiquitin Proteomics, Immunoprecipitation, Transfection, Construct, Mutagenesis

A Summary of ceramides that were up- or down-regulated following TM9SF2 depletion in H460 cells from lipidomics analysis. B PD-L1 levels were analyzed using Western blot in H460 cells administered cholesteryl:phosphatidylcholine (CholPC) alone or CholPC loaded with ceramides and derivatives (31.25 μM, 40 h). C PD-L1 surface levels in H460 cells given cholPC alone or cholPC loaded with ceramides and derivatives (31.25 μM, 40 h) ( n = 3 independent experiments). D , E Half-life analysis of PD-L1 or HIP1R concentrations in H460 cells overexpressing TM9SF2 for the indicated time points following CHX (25 µg/mL) treatment. Cells underwent pre-treated using 31.25 μM cholPC loaded with Cer(d18:1/26:0) for 40 h. F Co-immunoprecipitation analysis investigating the effect of Cer(d18:1/26:0) on the interaction between PGK1 and TM9SF2. HEK293T cells pre-transfected with HA- PGK1 or FLAG- TM9SF2 were treated with or without Cer(d18:1/26:0) (31.25 μM, 40 h). HA antibody is used for the detection of HA-tagged PGK1. G Immunofluorescence showing colocalization of PD-L1 with RAB11 in H460 cells with or without Cer(d18:1/26:0) treatment (31.25 μM, 40 h). (PD-L1 in green, RAB11 in red, DAPI in blue.) Scale bars: 4 μm. Intensity of PD-L1 and RAB11 following the white line are shown in right panels. H Schematic of the experimental protocol: For I – K , C57BL/6 J mice were subcutaneously inoculated with B16 cells and then administered intraperitoneal injections of either CholPC or Cer(d18:1/26:0) (10 and 20 mg/kg/day) for one week. All statistical comparisons were performed against the CholPC-treated control group. I Representative image of B16 tumors. J Proportion of tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). K IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Figure Legend Snippet: A Summary of ceramides that were up- or down-regulated following TM9SF2 depletion in H460 cells from lipidomics analysis. B PD-L1 levels were analyzed using Western blot in H460 cells administered cholesteryl:phosphatidylcholine (CholPC) alone or CholPC loaded with ceramides and derivatives (31.25 μM, 40 h). C PD-L1 surface levels in H460 cells given cholPC alone or cholPC loaded with ceramides and derivatives (31.25 μM, 40 h) ( n = 3 independent experiments). D , E Half-life analysis of PD-L1 or HIP1R concentrations in H460 cells overexpressing TM9SF2 for the indicated time points following CHX (25 µg/mL) treatment. Cells underwent pre-treated using 31.25 μM cholPC loaded with Cer(d18:1/26:0) for 40 h. F Co-immunoprecipitation analysis investigating the effect of Cer(d18:1/26:0) on the interaction between PGK1 and TM9SF2. HEK293T cells pre-transfected with HA- PGK1 or FLAG- TM9SF2 were treated with or without Cer(d18:1/26:0) (31.25 μM, 40 h). HA antibody is used for the detection of HA-tagged PGK1. G Immunofluorescence showing colocalization of PD-L1 with RAB11 in H460 cells with or without Cer(d18:1/26:0) treatment (31.25 μM, 40 h). (PD-L1 in green, RAB11 in red, DAPI in blue.) Scale bars: 4 μm. Intensity of PD-L1 and RAB11 following the white line are shown in right panels. H Schematic of the experimental protocol: For I – K , C57BL/6 J mice were subcutaneously inoculated with B16 cells and then administered intraperitoneal injections of either CholPC or Cer(d18:1/26:0) (10 and 20 mg/kg/day) for one week. All statistical comparisons were performed against the CholPC-treated control group. I Representative image of B16 tumors. J Proportion of tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). K IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Techniques Used: Western Blot, Immunoprecipitation, Transfection, Immunofluorescence, Control



Similar Products

98
ATCC h460 lung large cell carcinoma cell line
H460 Lung Large Cell Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pmc13122445-72-32-61?v=ATCC
Average 98 stars, based on 1 article reviews
h460 lung large cell carcinoma cell line - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

86
Procell Inc h460 cells
A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. <t>H460</t> cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
H460 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pmc13194821-296-10-12?v=Procell+Inc
Average 86 stars, based on 1 article reviews
h460 cells - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

98
ATCC human lung epithelial cells
A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. <t>H460</t> cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Human Lung Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pm41861982-50-0-30?v=ATCC
Average 98 stars, based on 1 article reviews
human lung epithelial cells - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

98
ATCC cell culture nci h460
A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. <t>H460</t> cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Cell Culture Nci H460, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/us12577301-755-0-15?v=ATCC
Average 98 stars, based on 1 article reviews
cell culture nci h460 - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

98
ATCC non small cell lung cancer cell lines nci h460
A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. <t>H460</t> cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Non Small Cell Lung Cancer Cell Lines Nci H460, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pmc13012240-33-16-57?v=ATCC
Average 98 stars, based on 1 article reviews
non small cell lung cancer cell lines nci h460 - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

98
ATCC nsclc cell lines
A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. <t>H460</t> cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.
Nsclc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pmc13096118-193-0-13?v=ATCC
Average 98 stars, based on 1 article reviews
nsclc cell lines - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

98
ATCC nci h460 cells
SLAM family member 7 expression is reduced in p53-deficient cells. A . Western blot analysis of indicated proteins in p53-proficient and p53-deficient A549 cells treated with the specified compounds for 30 hours. B . Relative SLAM family member 7 (SLAMF7) mRNA levels measured by semi-quantitative real-time polymerase chain reaction in p53-proficient and p53-deficient A549 and U-2 OS cells under the same treatment conditions. Statistical significance was calculated using a Student’s t-test (* p < 0.05, ** p < 0.01, *** p < 0.001). C . Protein expression in p53-proficient (+) and p53-deficient (-) U-2 OS. D . Protein expression in p53-proficient (+) and p53-deficient <t>(-)</t> <t>NCI-H460</t> cells. The SLAMF7 panel is shown with both short and long exposure times to visualize the protein bands in actinomycin D (ActD) and nutlin-3a (Nut3a) (A+N)-treated cells better
Nci H460 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pmc13072665-343-0-6?v=ATCC
Average 98 stars, based on 1 article reviews
nci h460 cells - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

98
ATCC h460 htb 177 lung adenocarcinoma cells
(A) Representative Western blots in which decreased Rnd3 expression is observed in A549 and <t>H460</t> cells transfected with two separate Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control cells at 24, 48, and 96 h post-transfection. Tubulin was used as a loading control, n = 4 (24 h), n = 5 (48 h), and n = 6 (96 h). (B, C) Percentage of cell viability compared with NSC cells at 24, 48, and 96 h post-transfection in (B) A549 and (C) H460 cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. (D) Flow cytometry of propidium iodine incorporation was performed 48 h post-transfection with Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) to deplete Rnd3 expression compared with non-silencing control in A549 cells (n = 5) and H460 cells (n = 3). Cell cycle statistical comparisons were performed for G1 and G2/M comparison using one-way ANOVA with Dunnett’s multiple comparison test. * P < 0.05, ns, not significant.
H460 Htb 177 Lung Adenocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h460+cells/pmc12932936-232-4-18?v=ATCC
Average 98 stars, based on 1 article reviews
h460 htb 177 lung adenocarcinoma cells - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

Image Search Results


A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. H460 cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Journal: Nature Communications

Article Title: Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity

doi: 10.1038/s41467-026-70764-x

Figure Lengend Snippet: A An outline of the CRISPR-Cas9-based deletion library screen targeting genes related to sphingolipid synthesis or transport essential for cell surface PD-L1 expression. H460 cells expressing Cas9 were mutagenized with a focused lentiviral sgRNA library and PD-L1 low cells enriched by FACS sorting. B Significant hits identified from cellular screens are shown. LFC: The log2 fold change of sgRNA. C PD-L1 expression in sgNTC and sg TM9SF1-4 H460 cells was analyzed by Western blot. NTC: No Template Control. D Western blot assessment to evaluate PD-L1 expression in H460 cells overexpressing FLAG-tagged TM9SF1-4 versus empty vector (EV). FLAG antibody is used for the detection of TM9SF1/3/4. TM9SF2 antibody is used for the detection of TM9SF2. E The lifetime of PD-L1 was assessed in sgNTC and sg TM9SF1-4 H460 cells administered cycloheximide (CHX, 25 µg/mL) over time. PD-L1 levels were standardized to GAPDH. F A schematic overview of the T-cell-reliant cytotoxicity is shown. H460 cells transduced using TM9SF2 -targeting sgRNA or control sgRNA were co-cultured with activated T cells. Cytotoxicity was evaluated through clonogenic assays, survival analyses, and apoptosis measurements. G Cell viability showing T-cell cytotoxicity in H460 cells with TM9SF2 depletion following activated T cells co-culture. H , I Quantitative analysis of IFN-γ and CD107a expression in CD8 + T cells derived from co-culture are shown ( n = 5 independent experiments). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Article Snippet: HEK293T cells (Procell Corporation, #CL-0005), B16-F10 cells (Procell Corporation, #CL-0319), H460 cells (Procell Corporation, #CL-0299), and mouse AML cells (C1498) (ATCC, #TIB-49) were incubated in Dulbecco’s Modified Eagle’s Medium (DMEM, containing 10% fetal bovine serum (FBS) as well as 1% penicillin-streptomycin) (37 °C, 5% CO 2 ).

Techniques: CRISPR, Expressing, Western Blot, Control, Plasmid Preparation, Cell Culture, Co-Culture Assay, Derivative Assay

A Top five identified positive regulators ranked by enrichment scores from the immunoprecipitation-mass spectrometry (IP-MS) screen. Immunoprecipitation was performed using anti-FLAG beads in HEK293T cells transfected using TM9SF2 -FLAG. For B – E , G , HA antibody is used for the detection of HA-tagged PGK1. B Co-immunoprecipitation assays validating the interactions between TM9SF2 and PGK1 in H460 cells after 48 h of IFN-γ stimulation (100 ng/mL). C Western blot analysis of PGK1 and PD-L1 in H460 cells transduced with PGK1 sgRNAs versus sgNTC or H460 cells overexpressing HA-tagged PGK1 ( n = 3 independent experiments). D Co-immunoprecipitation assays demonstrating the association between TM9SF2 and PGK1 wild-type, S203D (phosphorylation-mimetic mutant), or S203A (phosphorylation-deficient mutant). E Western blot analysis of PD-L1 levels in PGK1 -depleted H460 cells transfected with PGK1 wild type or phospho-mutants. F , G The half-life of PD-L1 was assessed in H460 cells with PGK1 depletion or overexpression following treatment with CHX (25 µg/mL). For H – J , C57BL/6 J mice underwent subcutaneous injection with B16 cells transduced with Pgk1 shRNA or control shRNA. H Representative images and volumes of B16 tumors. I Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). J Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). K Schematic of the experimental design: For L-N, C57BL/6 J mice were subcutaneously inoculated with B16 cells followed by daily intraperitoneal administration of DC-PGKI (a PGK1 inhibitor, 5 and 10 mg/kg) for one week. L Representative image of B16 tumors. M Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). N The proportions of IFN-γ + and CD107a + tumor-permeating CD8 + T cells in tumors ( n = 5 mice). For O – Q , C57BL/6 J mice were injected with B16 cells overexpressing Pgk1 or EV. O Representative image of B16 tumors. P Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Q Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Journal: Nature Communications

Article Title: Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity

doi: 10.1038/s41467-026-70764-x

Figure Lengend Snippet: A Top five identified positive regulators ranked by enrichment scores from the immunoprecipitation-mass spectrometry (IP-MS) screen. Immunoprecipitation was performed using anti-FLAG beads in HEK293T cells transfected using TM9SF2 -FLAG. For B – E , G , HA antibody is used for the detection of HA-tagged PGK1. B Co-immunoprecipitation assays validating the interactions between TM9SF2 and PGK1 in H460 cells after 48 h of IFN-γ stimulation (100 ng/mL). C Western blot analysis of PGK1 and PD-L1 in H460 cells transduced with PGK1 sgRNAs versus sgNTC or H460 cells overexpressing HA-tagged PGK1 ( n = 3 independent experiments). D Co-immunoprecipitation assays demonstrating the association between TM9SF2 and PGK1 wild-type, S203D (phosphorylation-mimetic mutant), or S203A (phosphorylation-deficient mutant). E Western blot analysis of PD-L1 levels in PGK1 -depleted H460 cells transfected with PGK1 wild type or phospho-mutants. F , G The half-life of PD-L1 was assessed in H460 cells with PGK1 depletion or overexpression following treatment with CHX (25 µg/mL). For H – J , C57BL/6 J mice underwent subcutaneous injection with B16 cells transduced with Pgk1 shRNA or control shRNA. H Representative images and volumes of B16 tumors. I Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). J Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). K Schematic of the experimental design: For L-N, C57BL/6 J mice were subcutaneously inoculated with B16 cells followed by daily intraperitoneal administration of DC-PGKI (a PGK1 inhibitor, 5 and 10 mg/kg) for one week. L Representative image of B16 tumors. M Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). N The proportions of IFN-γ + and CD107a + tumor-permeating CD8 + T cells in tumors ( n = 5 mice). For O – Q , C57BL/6 J mice were injected with B16 cells overexpressing Pgk1 or EV. O Representative image of B16 tumors. P Proportions of tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Q Flow cytometry analysis of IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Article Snippet: HEK293T cells (Procell Corporation, #CL-0005), B16-F10 cells (Procell Corporation, #CL-0319), H460 cells (Procell Corporation, #CL-0299), and mouse AML cells (C1498) (ATCC, #TIB-49) were incubated in Dulbecco’s Modified Eagle’s Medium (DMEM, containing 10% fetal bovine serum (FBS) as well as 1% penicillin-streptomycin) (37 °C, 5% CO 2 ).

Techniques: Immunoprecipitation, Mass Spectrometry, Protein-Protein interactions, Transfection, Western Blot, Transduction, Phospho-proteomics, Mutagenesis, Over Expression, Injection, shRNA, Control, Flow Cytometry

A Bar plot showing altered cellular processes and signaling pathways in shTM9SF2 H460 cells compared to shNC cells. B A schematic of the PD-L1 surface internalization assay in H460 cells transduced with sgRNAs is shown. C Surface PD-L1 retention in H460 cells was measured by flow cytometry after genetic depletion of PGK1 or TM9SF2 ( n = 3 independent experiments). D PD-L1 recycling was quantified by flow cytometry in H460 cells following PGK1 or TM9SF2 knockout ( n = 3 independent experiments). E Immunofluorescence showing PD-L1 colocalization with RAB11 in sg PGK1 or sg TM9SF2 H460 cells versus sgNTC (PD-L1 in green, RAB11 in red, DAPI in blue). Scale bar: 5 μm. The right panels display intensity profiles of PD-L1 versus RAB11 following the white line. For F , G , HA antibody is used for the detection of HA-tagged PGK1. F Co-immunoprecipitation assay demonstrating TM9SF2 interaction with PGK1, RAB11, and PD-L1 in H460 cells, with or without IFN-γ treatment (100 ng/mL, 48 h). G Co-immunoprecipitation assay evaluating interactions of PGK1 wild-type and its phospho-mutants (S203A and S203D) using TM9SF2, PD-L1, and RAB11 in H460 cells. Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Journal: Nature Communications

Article Title: Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity

doi: 10.1038/s41467-026-70764-x

Figure Lengend Snippet: A Bar plot showing altered cellular processes and signaling pathways in shTM9SF2 H460 cells compared to shNC cells. B A schematic of the PD-L1 surface internalization assay in H460 cells transduced with sgRNAs is shown. C Surface PD-L1 retention in H460 cells was measured by flow cytometry after genetic depletion of PGK1 or TM9SF2 ( n = 3 independent experiments). D PD-L1 recycling was quantified by flow cytometry in H460 cells following PGK1 or TM9SF2 knockout ( n = 3 independent experiments). E Immunofluorescence showing PD-L1 colocalization with RAB11 in sg PGK1 or sg TM9SF2 H460 cells versus sgNTC (PD-L1 in green, RAB11 in red, DAPI in blue). Scale bar: 5 μm. The right panels display intensity profiles of PD-L1 versus RAB11 following the white line. For F , G , HA antibody is used for the detection of HA-tagged PGK1. F Co-immunoprecipitation assay demonstrating TM9SF2 interaction with PGK1, RAB11, and PD-L1 in H460 cells, with or without IFN-γ treatment (100 ng/mL, 48 h). G Co-immunoprecipitation assay evaluating interactions of PGK1 wild-type and its phospho-mutants (S203A and S203D) using TM9SF2, PD-L1, and RAB11 in H460 cells. Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Article Snippet: HEK293T cells (Procell Corporation, #CL-0005), B16-F10 cells (Procell Corporation, #CL-0319), H460 cells (Procell Corporation, #CL-0299), and mouse AML cells (C1498) (ATCC, #TIB-49) were incubated in Dulbecco’s Modified Eagle’s Medium (DMEM, containing 10% fetal bovine serum (FBS) as well as 1% penicillin-streptomycin) (37 °C, 5% CO 2 ).

Techniques: Protein-Protein interactions, Transduction, Flow Cytometry, Knock-Out, Immunofluorescence, Co-Immunoprecipitation Assay

A Heatmap showing increased proteins involved in PD-L1 lysosomal degradation in sgPGK1 H460 cells versus sgNTC cells. Western blot of HIP1R levels in sg PGK1 ( B ) and sg TM9SF2 ( C ) H460 cells versus sgNTC cells ( n = 3 independent experiments). For D – F , HA antibody is used for the detection of HA-tagged PGK1. D Half-life analysis of HIP1R abundance in CHX (25 μg/mL)-treated H460 cells with PGK1 depletion or HA- PGK1 overexpression. E Western blot analyses of HIP1R ubiquitination in H460 cells reconstituted with MYC- HIP1R and HA- PGK1 for 36 h, followed by treatment with MG132 (10 μM, 8 h) and with or without IFN-γ administration (100 ng/mL, 8 h). MYC antibody is used for the detection of MYC-tagged HIP1R. F Western blot analyses of HIP1R ubiquitination in HEK293T cells reconstituted using MYC- HIP1R and HA- PGK1 wild-type and phospho-mutants for 36 h, followed by MG132 treatment (10 μM, 8 h). G Co-immunoprecipitation analysis examining IFN-γ effects on PGK1 association with GFP-HIP1R Δ966-979 and GFP-HIP1R. H460 cells transfected with FLAG- PGK1 and either GFP- HIP1R or GFP- HIP1R Δ966-979 were treated with IFN-γ (100 ng/mL, 8 h). Flag antibody is used for the detection of FLAG-tagged PGK1 and GFP antibody is used for the detection of GFP-tagged HIP1R. H A schematic of GFP fusion constructs is shown, including HIP1R lysosomal sorting signal (LL/LI, GFP-S1) and its corresponding mutant (AA, GFP-S2). I CHX-chase assay showing GFP-S1 and GFP-S2 protein levels over time in sg PGK1 or sgNTC H460 cells treated with CHX (25 μg/mL). Source data are provided as a file.

Journal: Nature Communications

Article Title: Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity

doi: 10.1038/s41467-026-70764-x

Figure Lengend Snippet: A Heatmap showing increased proteins involved in PD-L1 lysosomal degradation in sgPGK1 H460 cells versus sgNTC cells. Western blot of HIP1R levels in sg PGK1 ( B ) and sg TM9SF2 ( C ) H460 cells versus sgNTC cells ( n = 3 independent experiments). For D – F , HA antibody is used for the detection of HA-tagged PGK1. D Half-life analysis of HIP1R abundance in CHX (25 μg/mL)-treated H460 cells with PGK1 depletion or HA- PGK1 overexpression. E Western blot analyses of HIP1R ubiquitination in H460 cells reconstituted with MYC- HIP1R and HA- PGK1 for 36 h, followed by treatment with MG132 (10 μM, 8 h) and with or without IFN-γ administration (100 ng/mL, 8 h). MYC antibody is used for the detection of MYC-tagged HIP1R. F Western blot analyses of HIP1R ubiquitination in HEK293T cells reconstituted using MYC- HIP1R and HA- PGK1 wild-type and phospho-mutants for 36 h, followed by MG132 treatment (10 μM, 8 h). G Co-immunoprecipitation analysis examining IFN-γ effects on PGK1 association with GFP-HIP1R Δ966-979 and GFP-HIP1R. H460 cells transfected with FLAG- PGK1 and either GFP- HIP1R or GFP- HIP1R Δ966-979 were treated with IFN-γ (100 ng/mL, 8 h). Flag antibody is used for the detection of FLAG-tagged PGK1 and GFP antibody is used for the detection of GFP-tagged HIP1R. H A schematic of GFP fusion constructs is shown, including HIP1R lysosomal sorting signal (LL/LI, GFP-S1) and its corresponding mutant (AA, GFP-S2). I CHX-chase assay showing GFP-S1 and GFP-S2 protein levels over time in sg PGK1 or sgNTC H460 cells treated with CHX (25 μg/mL). Source data are provided as a file.

Article Snippet: HEK293T cells (Procell Corporation, #CL-0005), B16-F10 cells (Procell Corporation, #CL-0319), H460 cells (Procell Corporation, #CL-0299), and mouse AML cells (C1498) (ATCC, #TIB-49) were incubated in Dulbecco’s Modified Eagle’s Medium (DMEM, containing 10% fetal bovine serum (FBS) as well as 1% penicillin-streptomycin) (37 °C, 5% CO 2 ).

Techniques: Western Blot, Over Expression, Ubiquitin Proteomics, Immunoprecipitation, Transfection, Construct, Mutagenesis

A Summary of ceramides that were up- or down-regulated following TM9SF2 depletion in H460 cells from lipidomics analysis. B PD-L1 levels were analyzed using Western blot in H460 cells administered cholesteryl:phosphatidylcholine (CholPC) alone or CholPC loaded with ceramides and derivatives (31.25 μM, 40 h). C PD-L1 surface levels in H460 cells given cholPC alone or cholPC loaded with ceramides and derivatives (31.25 μM, 40 h) ( n = 3 independent experiments). D , E Half-life analysis of PD-L1 or HIP1R concentrations in H460 cells overexpressing TM9SF2 for the indicated time points following CHX (25 µg/mL) treatment. Cells underwent pre-treated using 31.25 μM cholPC loaded with Cer(d18:1/26:0) for 40 h. F Co-immunoprecipitation analysis investigating the effect of Cer(d18:1/26:0) on the interaction between PGK1 and TM9SF2. HEK293T cells pre-transfected with HA- PGK1 or FLAG- TM9SF2 were treated with or without Cer(d18:1/26:0) (31.25 μM, 40 h). HA antibody is used for the detection of HA-tagged PGK1. G Immunofluorescence showing colocalization of PD-L1 with RAB11 in H460 cells with or without Cer(d18:1/26:0) treatment (31.25 μM, 40 h). (PD-L1 in green, RAB11 in red, DAPI in blue.) Scale bars: 4 μm. Intensity of PD-L1 and RAB11 following the white line are shown in right panels. H Schematic of the experimental protocol: For I – K , C57BL/6 J mice were subcutaneously inoculated with B16 cells and then administered intraperitoneal injections of either CholPC or Cer(d18:1/26:0) (10 and 20 mg/kg/day) for one week. All statistical comparisons were performed against the CholPC-treated control group. I Representative image of B16 tumors. J Proportion of tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). K IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Journal: Nature Communications

Article Title: Ceramide disrupts TM9SF2-PGK1 axis to redirect PD-L1 trafficking and enhance antitumor immunity

doi: 10.1038/s41467-026-70764-x

Figure Lengend Snippet: A Summary of ceramides that were up- or down-regulated following TM9SF2 depletion in H460 cells from lipidomics analysis. B PD-L1 levels were analyzed using Western blot in H460 cells administered cholesteryl:phosphatidylcholine (CholPC) alone or CholPC loaded with ceramides and derivatives (31.25 μM, 40 h). C PD-L1 surface levels in H460 cells given cholPC alone or cholPC loaded with ceramides and derivatives (31.25 μM, 40 h) ( n = 3 independent experiments). D , E Half-life analysis of PD-L1 or HIP1R concentrations in H460 cells overexpressing TM9SF2 for the indicated time points following CHX (25 µg/mL) treatment. Cells underwent pre-treated using 31.25 μM cholPC loaded with Cer(d18:1/26:0) for 40 h. F Co-immunoprecipitation analysis investigating the effect of Cer(d18:1/26:0) on the interaction between PGK1 and TM9SF2. HEK293T cells pre-transfected with HA- PGK1 or FLAG- TM9SF2 were treated with or without Cer(d18:1/26:0) (31.25 μM, 40 h). HA antibody is used for the detection of HA-tagged PGK1. G Immunofluorescence showing colocalization of PD-L1 with RAB11 in H460 cells with or without Cer(d18:1/26:0) treatment (31.25 μM, 40 h). (PD-L1 in green, RAB11 in red, DAPI in blue.) Scale bars: 4 μm. Intensity of PD-L1 and RAB11 following the white line are shown in right panels. H Schematic of the experimental protocol: For I – K , C57BL/6 J mice were subcutaneously inoculated with B16 cells and then administered intraperitoneal injections of either CholPC or Cer(d18:1/26:0) (10 and 20 mg/kg/day) for one week. All statistical comparisons were performed against the CholPC-treated control group. I Representative image of B16 tumors. J Proportion of tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). K IFN-γ and CD107a levels in tumor-permeating CD8 + T cells in B16 tumors ( n = 5 mice). Data are presented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Source data are provided as a file.

Article Snippet: HEK293T cells (Procell Corporation, #CL-0005), B16-F10 cells (Procell Corporation, #CL-0319), H460 cells (Procell Corporation, #CL-0299), and mouse AML cells (C1498) (ATCC, #TIB-49) were incubated in Dulbecco’s Modified Eagle’s Medium (DMEM, containing 10% fetal bovine serum (FBS) as well as 1% penicillin-streptomycin) (37 °C, 5% CO 2 ).

Techniques: Western Blot, Immunoprecipitation, Transfection, Immunofluorescence, Control

SLAM family member 7 expression is reduced in p53-deficient cells. A . Western blot analysis of indicated proteins in p53-proficient and p53-deficient A549 cells treated with the specified compounds for 30 hours. B . Relative SLAM family member 7 (SLAMF7) mRNA levels measured by semi-quantitative real-time polymerase chain reaction in p53-proficient and p53-deficient A549 and U-2 OS cells under the same treatment conditions. Statistical significance was calculated using a Student’s t-test (* p < 0.05, ** p < 0.01, *** p < 0.001). C . Protein expression in p53-proficient (+) and p53-deficient (-) U-2 OS. D . Protein expression in p53-proficient (+) and p53-deficient (-) NCI-H460 cells. The SLAMF7 panel is shown with both short and long exposure times to visualize the protein bands in actinomycin D (ActD) and nutlin-3a (Nut3a) (A+N)-treated cells better

Journal: Cell Communication and Signaling : CCS

Article Title: The p53 tumor suppressor modulates the expression of proteins that control natural killer cell activity

doi: 10.1186/s12964-026-02772-9

Figure Lengend Snippet: SLAM family member 7 expression is reduced in p53-deficient cells. A . Western blot analysis of indicated proteins in p53-proficient and p53-deficient A549 cells treated with the specified compounds for 30 hours. B . Relative SLAM family member 7 (SLAMF7) mRNA levels measured by semi-quantitative real-time polymerase chain reaction in p53-proficient and p53-deficient A549 and U-2 OS cells under the same treatment conditions. Statistical significance was calculated using a Student’s t-test (* p < 0.05, ** p < 0.01, *** p < 0.001). C . Protein expression in p53-proficient (+) and p53-deficient (-) U-2 OS. D . Protein expression in p53-proficient (+) and p53-deficient (-) NCI-H460 cells. The SLAMF7 panel is shown with both short and long exposure times to visualize the protein bands in actinomycin D (ActD) and nutlin-3a (Nut3a) (A+N)-treated cells better

Article Snippet: NCI-H460 cells (RRID: CVCL_0459, lung cancer, ATCC) and WM793B cells (RRID: CVCL_8787, melanoma) were cultured in RPMI-1640 supplemented with 2 mM L-glutamine, 4.5 g/L glucose, 1 mM sodium pyruvate, and 10% heat-inactivated FBS.

Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction

Co-treatment with actinomycin D and nutlin-3a sensitizes cancer cells to killing by NK-92 cells. A . Viability of A549 cells measured by MTS assay. Cells were either mock-treated (Con) or treated with actinomycin D (ActD) and nutlin-3a (Nut3a) combined (A+N) for 48 hours, then trypsinized, counted, and incubated for 24 hours in RPMI1640 medium alone or in co-culture with NK-92 cells at two effector-to-target (E: T) ratios (NK-92: A549 – 1:1 and 5:1) for 24 hours. After co-incubation, the medium was replaced with DMEM, and the A549 cells were allowed to recover for 72 hours before assessing metabolic activity via the MTS assay. Five biological replicates were performed. Viability of mock-control cells and drug-treated cells without NK-92 exposure was set to 100%. Statistical analysis: ordinary one-way ANOVA and multiple comparisons test (** p < 0.01, **** p < 0.0001). B . MTS assay of A549 cells pre-treated for 48 hours with ActD, Nut3a, or A+N, followed by 24 hours of co-incubation with NK-92 cells. Viability was assessed as in A . Four biological replicates were analyzed. Statistical analysis: ordinary one-way ANOVA and multiple comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). C . Viability of NCI-H460 cells pre-exposed to A+N or Con for 48 hours, followed by 24 hours of co-incubation with the NK-92 cell line at a 1:1 ratio. Viability was assessed as in A . Statistical significance: unpaired, two-tailed t-test (*** p < 0.001). D . Macroscopic visualization of A549 cells surviving NK-92-mediated killing. Cells were pre-treated for 48 hours with A+N or Con, then seeded on a 6-well plate with or without NK-92 cells at E: T ratios of 1:1 or 5:1 (NK-92:A549). After a 24-hour co-incubation, the RPMI medium for NK-92 cells was replaced with fresh DMEM, and the A549 cells were allowed to recover for 5-7 days. Remaining adherent cells were fixed with methanol and stained with 0.01% crystal violet. Representative results from three biological replicates are shown

Journal: Cell Communication and Signaling : CCS

Article Title: The p53 tumor suppressor modulates the expression of proteins that control natural killer cell activity

doi: 10.1186/s12964-026-02772-9

Figure Lengend Snippet: Co-treatment with actinomycin D and nutlin-3a sensitizes cancer cells to killing by NK-92 cells. A . Viability of A549 cells measured by MTS assay. Cells were either mock-treated (Con) or treated with actinomycin D (ActD) and nutlin-3a (Nut3a) combined (A+N) for 48 hours, then trypsinized, counted, and incubated for 24 hours in RPMI1640 medium alone or in co-culture with NK-92 cells at two effector-to-target (E: T) ratios (NK-92: A549 – 1:1 and 5:1) for 24 hours. After co-incubation, the medium was replaced with DMEM, and the A549 cells were allowed to recover for 72 hours before assessing metabolic activity via the MTS assay. Five biological replicates were performed. Viability of mock-control cells and drug-treated cells without NK-92 exposure was set to 100%. Statistical analysis: ordinary one-way ANOVA and multiple comparisons test (** p < 0.01, **** p < 0.0001). B . MTS assay of A549 cells pre-treated for 48 hours with ActD, Nut3a, or A+N, followed by 24 hours of co-incubation with NK-92 cells. Viability was assessed as in A . Four biological replicates were analyzed. Statistical analysis: ordinary one-way ANOVA and multiple comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). C . Viability of NCI-H460 cells pre-exposed to A+N or Con for 48 hours, followed by 24 hours of co-incubation with the NK-92 cell line at a 1:1 ratio. Viability was assessed as in A . Statistical significance: unpaired, two-tailed t-test (*** p < 0.001). D . Macroscopic visualization of A549 cells surviving NK-92-mediated killing. Cells were pre-treated for 48 hours with A+N or Con, then seeded on a 6-well plate with or without NK-92 cells at E: T ratios of 1:1 or 5:1 (NK-92:A549). After a 24-hour co-incubation, the RPMI medium for NK-92 cells was replaced with fresh DMEM, and the A549 cells were allowed to recover for 5-7 days. Remaining adherent cells were fixed with methanol and stained with 0.01% crystal violet. Representative results from three biological replicates are shown

Article Snippet: NCI-H460 cells (RRID: CVCL_0459, lung cancer, ATCC) and WM793B cells (RRID: CVCL_8787, melanoma) were cultured in RPMI-1640 supplemented with 2 mM L-glutamine, 4.5 g/L glucose, 1 mM sodium pyruvate, and 10% heat-inactivated FBS.

Techniques: MTS Assay, Incubation, Co-Culture Assay, Activity Assay, Control, Two Tailed Test, Staining

(A) Representative Western blots in which decreased Rnd3 expression is observed in A549 and H460 cells transfected with two separate Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control cells at 24, 48, and 96 h post-transfection. Tubulin was used as a loading control, n = 4 (24 h), n = 5 (48 h), and n = 6 (96 h). (B, C) Percentage of cell viability compared with NSC cells at 24, 48, and 96 h post-transfection in (B) A549 and (C) H460 cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. (D) Flow cytometry of propidium iodine incorporation was performed 48 h post-transfection with Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) to deplete Rnd3 expression compared with non-silencing control in A549 cells (n = 5) and H460 cells (n = 3). Cell cycle statistical comparisons were performed for G1 and G2/M comparison using one-way ANOVA with Dunnett’s multiple comparison test. * P < 0.05, ns, not significant.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A) Representative Western blots in which decreased Rnd3 expression is observed in A549 and H460 cells transfected with two separate Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control cells at 24, 48, and 96 h post-transfection. Tubulin was used as a loading control, n = 4 (24 h), n = 5 (48 h), and n = 6 (96 h). (B, C) Percentage of cell viability compared with NSC cells at 24, 48, and 96 h post-transfection in (B) A549 and (C) H460 cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. (D) Flow cytometry of propidium iodine incorporation was performed 48 h post-transfection with Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) to deplete Rnd3 expression compared with non-silencing control in A549 cells (n = 5) and H460 cells (n = 3). Cell cycle statistical comparisons were performed for G1 and G2/M comparison using one-way ANOVA with Dunnett’s multiple comparison test. * P < 0.05, ns, not significant.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Western Blot, Expressing, Transfection, Control, Flow Cytometry, Comparison

(A, B) Quantification of representative Western blots with samples used in cell viability and cell cycle assays in , of Rnd3 expression after 24, 48, and 96 h of transient transfection with two separate Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control cells in (A) A549 cells, n = 4, and (B) H460 cells, n = 3. Densitometric analysis was performed for each sample set; the expression level of Rnd3 was normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, **** P < 0.0001.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A, B) Quantification of representative Western blots with samples used in cell viability and cell cycle assays in , of Rnd3 expression after 24, 48, and 96 h of transient transfection with two separate Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control cells in (A) A549 cells, n = 4, and (B) H460 cells, n = 3. Densitometric analysis was performed for each sample set; the expression level of Rnd3 was normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, **** P < 0.0001.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Western Blot, Expressing, Transfection, Control

(A, B, C) Decreased Rnd3 expression is observed in A549 and H460 cells transfected with Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control (NSC) cells. Tubulin was used as a loading control. (A, B, C) Representative Western blots and (B, C) densitometric analysis were performed for each sample set; the expression level of Rnd3 was normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells in (B) A549 and (C) H460 cells, n = 4. (D, E, F) Invasion assay across a transwell membrane coated with Matrigel. (D, E) Percentage of invaded cells compared with NSC cells at (D) 24 h for A549 cells (n = 6) and (E) 48 h for H460 cells (n = 4). Data are presented as an individual mean for each experiment, and normalized to own NSC, with bar representing overall mean ± SEM. (F) Representative images of invading cells at 24 h (A549) and 48 h (H460), 10× magnification; scale bar = 100 μm. (G, H, I, J, K) Wound healing assays. (G, H) Time course, percentage wound closure at each time-point compared with wound at 0 h, for (G) A549 cells and (H) H460 cells; data are presented as mean ± SEM. (I, J) Percentage wound closure at (I) 24 h (A549 cells, n = 6) and (J) 48 h (H460 cells, n = 6) compared with wound at 0 h. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. (K) Representative images of wound closure at 0 h and either 24 h for A549 or 48 h for H460 cells, 10× magnification; scale bar = 100 μm. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A, B, C) Decreased Rnd3 expression is observed in A549 and H460 cells transfected with Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control (NSC) cells. Tubulin was used as a loading control. (A, B, C) Representative Western blots and (B, C) densitometric analysis were performed for each sample set; the expression level of Rnd3 was normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells in (B) A549 and (C) H460 cells, n = 4. (D, E, F) Invasion assay across a transwell membrane coated with Matrigel. (D, E) Percentage of invaded cells compared with NSC cells at (D) 24 h for A549 cells (n = 6) and (E) 48 h for H460 cells (n = 4). Data are presented as an individual mean for each experiment, and normalized to own NSC, with bar representing overall mean ± SEM. (F) Representative images of invading cells at 24 h (A549) and 48 h (H460), 10× magnification; scale bar = 100 μm. (G, H, I, J, K) Wound healing assays. (G, H) Time course, percentage wound closure at each time-point compared with wound at 0 h, for (G) A549 cells and (H) H460 cells; data are presented as mean ± SEM. (I, J) Percentage wound closure at (I) 24 h (A549 cells, n = 6) and (J) 48 h (H460 cells, n = 6) compared with wound at 0 h. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. (K) Representative images of wound closure at 0 h and either 24 h for A549 or 48 h for H460 cells, 10× magnification; scale bar = 100 μm. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Expressing, Transfection, Control, Western Blot, Invasion Assay, Membrane

(A, B, C, D) 24-h treatment with 5 μM Y-27632 (+Y) induces the loss of actin stress fibers compared with DMSO control (−Y) in (A, C) A549 and (B, D) H460 cells. (A, B) Representative epifluorescence images of the actin stain phalloidin (white). White arrows highlight actin stress fibers, 60× magnification; scale bar = 50 μm. (C, D) Quantification of actin stress fibers; five fields of view were imaged using a 60× oil objective, a total number of actin stress fibers per cell in five cells per field of view were counted, and the average actin stress fiber number per cell was calculated and normalized to own DMSO-treated NSC for each condition per biological repeat, n = 3. (E, F, G, H) Invasion assay across a transwell membrane coated with Matrigel, treated with 5 μM Y-27632 (+Y) or DMSO as a control (−Y). (E, F) Percentage of invaded cells compared with DMSO-treated NSC (−Y) cells at (E) 24 h for A549 and (F) 48 h for H460 cells, n = >4; data are presented as mean ± SEM. (G, H) Representative images of invading cells at (G) 24 h for A549 and (H) 48 h for H460 cells, 10× magnification; scale bar = 100 μm. (I, J) Wound healing assay, treated with 5 μM Y-27632 (+Y) or DMSO control (−Y). (I) Time course, percentage wound closure for A549 cells at each time-point compared with wound at 0 h, and data are presented as mean ± SEM. (J) Percentage wound closure for A549 cells at 24 h compared with wound at 0 h, n = 4. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM; statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant. (K) Representative Western blots of samples used in above experiment, in which decreased Rnd3 expression is observed in A549 and H460 cells transfected with siRNA oligos A (Rnd3(A)) and D (Rnd3(D)), treated with 5 μM Y-27632 (+Y) or DMSO (−Y). Tubulin was used as a loading control.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A, B, C, D) 24-h treatment with 5 μM Y-27632 (+Y) induces the loss of actin stress fibers compared with DMSO control (−Y) in (A, C) A549 and (B, D) H460 cells. (A, B) Representative epifluorescence images of the actin stain phalloidin (white). White arrows highlight actin stress fibers, 60× magnification; scale bar = 50 μm. (C, D) Quantification of actin stress fibers; five fields of view were imaged using a 60× oil objective, a total number of actin stress fibers per cell in five cells per field of view were counted, and the average actin stress fiber number per cell was calculated and normalized to own DMSO-treated NSC for each condition per biological repeat, n = 3. (E, F, G, H) Invasion assay across a transwell membrane coated with Matrigel, treated with 5 μM Y-27632 (+Y) or DMSO as a control (−Y). (E, F) Percentage of invaded cells compared with DMSO-treated NSC (−Y) cells at (E) 24 h for A549 and (F) 48 h for H460 cells, n = >4; data are presented as mean ± SEM. (G, H) Representative images of invading cells at (G) 24 h for A549 and (H) 48 h for H460 cells, 10× magnification; scale bar = 100 μm. (I, J) Wound healing assay, treated with 5 μM Y-27632 (+Y) or DMSO control (−Y). (I) Time course, percentage wound closure for A549 cells at each time-point compared with wound at 0 h, and data are presented as mean ± SEM. (J) Percentage wound closure for A549 cells at 24 h compared with wound at 0 h, n = 4. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM; statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant. (K) Representative Western blots of samples used in above experiment, in which decreased Rnd3 expression is observed in A549 and H460 cells transfected with siRNA oligos A (Rnd3(A)) and D (Rnd3(D)), treated with 5 μM Y-27632 (+Y) or DMSO (−Y). Tubulin was used as a loading control.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Control, Staining, Invasion Assay, Membrane, Wound Healing Assay, Western Blot, Expressing, Transfection

(A, B) Quantification of representative Western blots of samples used in cell migration and invasion assays treated with either 5 μM Y-27632 (+Y) or DMSO control (−Y) in , (A) A549 cells, n = 4, and (B) H460 cells, n = 3. Densitometric analysis was performed for each sample set; the expression level of Rnd3 was normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. (C, D, E, F) 24-h treatment with either 5 or 10 μM Y-27632 (Y) induces the loss of actin stress fibers compared with their corresponding DMSO control in (C, E) A549 cells, n = 4, and (D, F) H460 cells, n = 3. (C, D) Epifluorescence images of actin stain phalloidin (white). White arrows highlight actin stress fibers; scale bar = 50 μm. (E, F) Quantification of actin stress fibers; five fields of view were imaged using a 60x oil objective, the total number of actin stress fibers per cell in five cells per field of view was counted, and average actin stress fiber number per cell was calculated and normalized to own DMSO-treated cells for each condition per biological repeat. (G, H) Invasion assay across a transwell membrane coated with Matrigel, treated with 5 or 10 μM Y-27632 (Y) or corresponding DMSO control. (F, G) Percentage of invaded cells compared with DMSO-treated cells at (G) 24 h for A549 and (F) 48 h for H460 cells, n = >4. Data are presented as an individual mean for each experiment, and normalized to own DMSO-treated cells, with bar representing overall mean ± SEM. * P < 0.05, ** P < 0.01, **** P < 0.0001, ns, not significant.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A, B) Quantification of representative Western blots of samples used in cell migration and invasion assays treated with either 5 μM Y-27632 (+Y) or DMSO control (−Y) in , (A) A549 cells, n = 4, and (B) H460 cells, n = 3. Densitometric analysis was performed for each sample set; the expression level of Rnd3 was normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. (C, D, E, F) 24-h treatment with either 5 or 10 μM Y-27632 (Y) induces the loss of actin stress fibers compared with their corresponding DMSO control in (C, E) A549 cells, n = 4, and (D, F) H460 cells, n = 3. (C, D) Epifluorescence images of actin stain phalloidin (white). White arrows highlight actin stress fibers; scale bar = 50 μm. (E, F) Quantification of actin stress fibers; five fields of view were imaged using a 60x oil objective, the total number of actin stress fibers per cell in five cells per field of view was counted, and average actin stress fiber number per cell was calculated and normalized to own DMSO-treated cells for each condition per biological repeat. (G, H) Invasion assay across a transwell membrane coated with Matrigel, treated with 5 or 10 μM Y-27632 (Y) or corresponding DMSO control. (F, G) Percentage of invaded cells compared with DMSO-treated cells at (G) 24 h for A549 and (F) 48 h for H460 cells, n = >4. Data are presented as an individual mean for each experiment, and normalized to own DMSO-treated cells, with bar representing overall mean ± SEM. * P < 0.05, ** P < 0.01, **** P < 0.0001, ns, not significant.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Western Blot, Migration, Control, Expressing, Staining, Invasion Assay, Membrane

(A) Representative Western blots comparing expression and phosphorylation levels of ROCK1 downstream targets: pMLC2, total MLC2, pCofilin, and total Cofilin, in A549 and H460 cells transfected for 48 h with Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control cells. Tubulin was used as a loading control. (B, C, D, E, F, G, H, I) Quantification of representative Western blots; densitometric analysis was performed for each sample set over multiple biological replicates to include quantification of Rnd3 and pCofilin expression levels of (B, C) A549, n = 4, and (D, E) H460 cells, n = 5, and Rnd3 and pMLC2 expression levels of (F, G) A549 cells, n = 6, and (H, I) H460 cells, n = 4, compared with NSC cells. (B, D, F, H) Quantification of Rnd3 siRNA knockdown for each sample set; expression levels of Rnd3 were normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells. (C, E) Expression levels of pCofilin were normalized to own tubulin loading control, then normalized to the expression level of pCofilin in the NSC cells. (G, I) Expression levels of pMLC2 were normalized to own tubulin loading control, then normalized to the expression level of pMLC2 in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. *** P < 0.001, **** P < 0.0001, ns, not significant.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A) Representative Western blots comparing expression and phosphorylation levels of ROCK1 downstream targets: pMLC2, total MLC2, pCofilin, and total Cofilin, in A549 and H460 cells transfected for 48 h with Rnd3 siRNA oligos A (Rnd3(A)) and D (Rnd3(D)) compared with non-silencing control cells. Tubulin was used as a loading control. (B, C, D, E, F, G, H, I) Quantification of representative Western blots; densitometric analysis was performed for each sample set over multiple biological replicates to include quantification of Rnd3 and pCofilin expression levels of (B, C) A549, n = 4, and (D, E) H460 cells, n = 5, and Rnd3 and pMLC2 expression levels of (F, G) A549 cells, n = 6, and (H, I) H460 cells, n = 4, compared with NSC cells. (B, D, F, H) Quantification of Rnd3 siRNA knockdown for each sample set; expression levels of Rnd3 were normalized to own tubulin loading control, then normalized to the expression level of Rnd3 in the NSC cells. (C, E) Expression levels of pCofilin were normalized to own tubulin loading control, then normalized to the expression level of pCofilin in the NSC cells. (G, I) Expression levels of pMLC2 were normalized to own tubulin loading control, then normalized to the expression level of pMLC2 in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. *** P < 0.001, **** P < 0.0001, ns, not significant.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Western Blot, Expressing, Phospho-proteomics, Transfection, Control, Knockdown

(A, B, C) Representative Western blots in which decreased protein expression levels of Rnd3 (oligo A), ROCK1, and ROCK2 are observed, corresponding to siRNA treatment compared with non-silencing control (NSC) in (A) A549, (B) H460, and (C) A375 cells (as an experimental control). Tubulin was used as a loading control. (D, E, F) Invasion assay across a transwell membrane coated with Matrigel, percentage of invaded cells compared with NSC cells at (D) 24 h for A549, n = >4, (E) 48 h for H460, n = 6, and (F) 16 h for A375 cells, n = 3 (as an experimental control). (G, H) A549 wound healing assay. (G) Time course, percentage wound closure at each time-point compared with wound at 0 h, and data are presented as mean ± SEM. (H) Percentage wound closure at 24 h compared with wound at 0 h, n = 5. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A, B, C) Representative Western blots in which decreased protein expression levels of Rnd3 (oligo A), ROCK1, and ROCK2 are observed, corresponding to siRNA treatment compared with non-silencing control (NSC) in (A) A549, (B) H460, and (C) A375 cells (as an experimental control). Tubulin was used as a loading control. (D, E, F) Invasion assay across a transwell membrane coated with Matrigel, percentage of invaded cells compared with NSC cells at (D) 24 h for A549, n = >4, (E) 48 h for H460, n = 6, and (F) 16 h for A375 cells, n = 3 (as an experimental control). (G, H) A549 wound healing assay. (G) Time course, percentage wound closure at each time-point compared with wound at 0 h, and data are presented as mean ± SEM. (H) Percentage wound closure at 24 h compared with wound at 0 h, n = 5. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Western Blot, Expressing, Control, Invasion Assay, Membrane, Wound Healing Assay

(A, B, C, D, E, F, G, H, I) Quantification of representative Western blots with samples used in cell migration and cell invasion assays in . Densitometric analysis was performed for each sample set over multiple biological replicates for Rnd3 (A, D, G), ROCK1 (B, E, H), and ROCK2 (C, F, I) expression after transient transfection with siRNA oligo compared with expression levels in non-silencing control cells in (A, B, C) A549, n = 5, (D, E, F) H460, n = 4, and (G, H, I) A375 cells, n = 3. Expression levels of each protein of interest were normalized to own tubulin loading control, then normalized to the expression level of the protein of interest in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A, B, C, D, E, F, G, H, I) Quantification of representative Western blots with samples used in cell migration and cell invasion assays in . Densitometric analysis was performed for each sample set over multiple biological replicates for Rnd3 (A, D, G), ROCK1 (B, E, H), and ROCK2 (C, F, I) expression after transient transfection with siRNA oligo compared with expression levels in non-silencing control cells in (A, B, C) A549, n = 5, (D, E, F) H460, n = 4, and (G, H, I) A375 cells, n = 3. Expression levels of each protein of interest were normalized to own tubulin loading control, then normalized to the expression level of the protein of interest in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Western Blot, Migration, Expressing, Transfection, Control

(A) Wound healing assay using A549 cells, and percentage wound closure at 24 h compared with wound at 0 h. (B) Invasion assay across a transwell membrane coated with Matrigel, and percentage of invaded cells compared with NSC H460 cells at 48 h. (C) Representative Western blots in which decreased protein expression levels of Rnd3 (oligo A) and RhoA (oligos 1 & 2) are observed, corresponding to siRNA treatment compared with non-silencing control, A549, and H460 cells. Tubulin was used as a loading control. (D, E, F, G) Quantification of representative Western blots. Densitometric analysis was performed for each sample set over multiple biological replicates for Rnd3 (D, F) and RhoA (E, G) expression after transient transfection with siRNA oligo compared with expression levels in NSC cells in (D, E) A549 and (F, G) H460 cells, n = 4. Expression levels of each protein of interest were normalized to own tubulin loading control, then normalized to the expression level of that protein of interest in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Life Science Alliance

Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

doi: 10.26508/lsa.202503494

Figure Lengend Snippet: (A) Wound healing assay using A549 cells, and percentage wound closure at 24 h compared with wound at 0 h. (B) Invasion assay across a transwell membrane coated with Matrigel, and percentage of invaded cells compared with NSC H460 cells at 48 h. (C) Representative Western blots in which decreased protein expression levels of Rnd3 (oligo A) and RhoA (oligos 1 & 2) are observed, corresponding to siRNA treatment compared with non-silencing control, A549, and H460 cells. Tubulin was used as a loading control. (D, E, F, G) Quantification of representative Western blots. Densitometric analysis was performed for each sample set over multiple biological replicates for Rnd3 (D, F) and RhoA (E, G) expression after transient transfection with siRNA oligo compared with expression levels in NSC cells in (D, E) A549 and (F, G) H460 cells, n = 4. Expression levels of each protein of interest were normalized to own tubulin loading control, then normalized to the expression level of that protein of interest in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

Techniques: Wound Healing Assay, Invasion Assay, Membrane, Western Blot, Expressing, Control, Transfection